Project deliverable Open Access

FAIRplus: D1.2 Selection criteria and guidelines for data sources from IMI projects and EFPIA internal databases

Gribbon, Philip; Gu, Wei; Sanz, Ferran; Ioannidis, Vassilios; Engkvist, Ola; Henderson, David; Reilly, Dorothy; Rocca-Serra, Philippe; Zaliani, Andrea; Witt, Gesa; Kohler, Manfred; Giessmann, Robert


DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="DOI">10.5281/zenodo.3596024</identifier>
  <creators>
    <creator>
      <creatorName>Gribbon, Philip</creatorName>
      <givenName>Philip</givenName>
      <familyName>Gribbon</familyName>
      <affiliation>Fraunhofer E.V</affiliation>
    </creator>
    <creator>
      <creatorName>Gu, Wei</creatorName>
      <givenName>Wei</givenName>
      <familyName>Gu</familyName>
      <affiliation>University of Luxembourg</affiliation>
    </creator>
    <creator>
      <creatorName>Sanz, Ferran</creatorName>
      <givenName>Ferran</givenName>
      <familyName>Sanz</familyName>
      <affiliation>Barcelona Supercomputing Centre</affiliation>
    </creator>
    <creator>
      <creatorName>Ioannidis, Vassilios</creatorName>
      <givenName>Vassilios</givenName>
      <familyName>Ioannidis</familyName>
      <affiliation>Swiss Institute of Bioinformatics</affiliation>
    </creator>
    <creator>
      <creatorName>Engkvist, Ola</creatorName>
      <givenName>Ola</givenName>
      <familyName>Engkvist</familyName>
      <affiliation>AstraZeneca AB</affiliation>
    </creator>
    <creator>
      <creatorName>Henderson, David</creatorName>
      <givenName>David</givenName>
      <familyName>Henderson</familyName>
      <affiliation>Bayer</affiliation>
    </creator>
    <creator>
      <creatorName>Reilly, Dorothy</creatorName>
      <givenName>Dorothy</givenName>
      <familyName>Reilly</familyName>
      <affiliation>Novartis Pharmaceuticals</affiliation>
    </creator>
    <creator>
      <creatorName>Rocca-Serra, Philippe</creatorName>
      <givenName>Philippe</givenName>
      <familyName>Rocca-Serra</familyName>
      <affiliation>University of Oxford</affiliation>
    </creator>
    <creator>
      <creatorName>Zaliani, Andrea</creatorName>
      <givenName>Andrea</givenName>
      <familyName>Zaliani</familyName>
      <affiliation>Fraunhofer E.V</affiliation>
    </creator>
    <creator>
      <creatorName>Witt, Gesa</creatorName>
      <givenName>Gesa</givenName>
      <familyName>Witt</familyName>
      <affiliation>Fraunhofer E.V</affiliation>
    </creator>
    <creator>
      <creatorName>Kohler, Manfred</creatorName>
      <givenName>Manfred</givenName>
      <familyName>Kohler</familyName>
      <affiliation>Fraunhofer E.V</affiliation>
    </creator>
    <creator>
      <creatorName>Giessmann, Robert</creatorName>
      <givenName>Robert</givenName>
      <familyName>Giessmann</familyName>
      <affiliation>Bayer</affiliation>
    </creator>
  </creators>
  <titles>
    <title>FAIRplus: D1.2 Selection criteria and guidelines for data sources from IMI projects and EFPIA internal databases</title>
  </titles>
  <publisher>Zenodo</publisher>
  <publicationYear>2019</publicationYear>
  <subjects>
    <subject>FAIRplus</subject>
    <subject>FAIRification</subject>
    <subject>IMI2 JU</subject>
    <subject>Innovative Medicines Initiative</subject>
    <subject>Datasets</subject>
    <subject>Guidelies</subject>
    <subject>H2020</subject>
    <subject>Societal priorities</subject>
  </subjects>
  <dates>
    <date dateType="Issued">2019-12-31</date>
  </dates>
  <resourceType resourceTypeGeneral="Text">Project deliverable</resourceType>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://zenodo.org/record/3596024</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsVersionOf">10.5281/zenodo.3596023</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="https://creativecommons.org/licenses/by/4.0/legalcode">Creative Commons Attribution 4.0 International</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">&lt;p&gt;Creating selection criteria and guidelines, to aid identification of IMI datasets with the potential to generate high societal impact upon FAIRification, is an important goal of FAIRplus. This deliverable report describes the process put in place to identify, evaluate and select projects. Two thirds of projects to be addressed by FAIRplus will cover societal priorities of H2020, namely; 1) promoting healthy ageing&lt;a&gt;&lt;sup&gt;&lt;sup&gt;[1]&lt;/sup&gt;&lt;/sup&gt;&lt;/a&gt;; 2) addressing chronic diseases; 3) neurodegenerative diseases and 4) emergence of antibiotic resistance. In addition, we have identified cross-cutting projects &amp;ldquo;Cross&amp;rdquo; which provide tools&amp;nbsp;&amp;nbsp;such as cell lines, biomarkers and animal models, which enable research progression in the primary priority areas. In the first period, some 25 projects have been identified based on the application of the criteria and discussions are ongoing with these consortia representatives&amp;nbsp;&amp;nbsp;in order to provide a steady flow of datasets into FAIRplus.&lt;/p&gt;

&lt;p&gt;&amp;nbsp;&lt;/p&gt;

&lt;p&gt;&lt;a&gt;&lt;sup&gt;&lt;sup&gt;[1]&lt;/sup&gt;&lt;/sup&gt;&lt;/a&gt;&amp;nbsp;see&amp;nbsp;&amp;nbsp;&lt;a href="http://ec.europa.eu/programmes/horizon2020/en/h2020-section/health-demographic-change-and-wellbeing"&gt;http://ec.europa.eu/programmes/horizon2020/en/h2020-section/health-demographic-change-and-wellbeing&lt;/a&gt;&lt;/p&gt;</description>
    <description descriptionType="Other">This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 802750. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation and EFPIA companies.</description>
  </descriptions>
  <fundingReferences>
    <fundingReference>
      <funderName>European Commission</funderName>
      <funderIdentifier funderIdentifierType="Crossref Funder ID">10.13039/501100000780</funderIdentifier>
      <awardNumber awardURI="info:eu-repo/grantAgreement/EC/H2020/802750/">802750</awardNumber>
      <awardTitle>FAIRplus</awardTitle>
    </fundingReference>
  </fundingReferences>
</resource>
275
198
views
downloads
All versions This version
Views 275275
Downloads 198198
Data volume 213.4 MB213.4 MB
Unique views 252252
Unique downloads 183183

Share

Cite as